Column Group LLC
Follow13F filer, CIK 1833486, San Francisco, CA
Column Group LLC reported $69,578,070 across 6 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-011839
- Period
- 2024-09-30
- Reported value
- $69.6M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000950123-24-011839, largest first. % of portfolio is the value over $69,578,070, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ORICORIC PHARMACEUTICALS INC | 3,540,777 | $36.3M | 52.16% | 0 | Timeline | ||
| TNYATENAYA THERAPEUTICS INC | 9,400,290 | $18.1M | 26.08% | 0 | Timeline | ||
| Surrozen, Inc.Surrozen, Inc. | 810,088 | $9.7M | 13.95% | 0 | |||
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 2,680,621 | $5.39M | 7.74% | 0 | |||
| SGMTSAGIMET BIOSCIENCES INC | 17,169 | $47.6K | 0.07% | 0 | Timeline | ||
| RVMDREVOLUTION MEDICINES INC | 46 | $2.09K | <0.01% | 0 | Timeline |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-24-011839 | base | 2024-11-14 | acceptance time not in the bulk data set |